TECH News Today | Why did Bio-Techne stock go up today?

Jan 6, 2025 · Shares of Bio-Techne Co. (NASDAQ:TECH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the …

$1.78
OFF

Bio-Techne Corporation (TECH) Latest Stock News - Seeking Alpha

2 weeks from now

Bio-Techne Non-GAAP EPS of $1.78 misses by $0.05, revenue of $269.65M misses by $12.08M SA News Tue, Nov. 01, 2022 Bio-Techne declares $0.32 dividend; announces 4-for-1 split in …

seekingalpha.com

1%
OFF

TECH Stock Likely To Gain From The Development - Yahoo Finance

2 weeks from now

3 days ago · Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on …

yahoo.com

5%
OFF

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up In …

2 weeks from now

Oct 30, 2024 · News. Latest ; Stock Market ; Originals ; ... shares of TECH rose 4.5% in pre-market trading today. Stay up-to-date with all ... TECH's Q1 Revenues in Detail. Bio-Techne …

yahoo.com

50%
OFF

Bio-techne Stock Price Forecast. Should You Buy TECH?

2 weeks from now

6 days ago · The Bio-Techne Corp stock price fell by -2.50% on the last day (Friday, 10th Jan 2025) from $75.19 to $73.31. During the last trading day the stock fluctuated 2.56% from a day …

stockinvest.us

97%
OFF

Bio-Techne (TECH) Market Cap Today: Live Data & Historical Trends

2 weeks from now

2 days ago · As of Jan 14, 2025, Bio-Techne (TECH) has a market capitalization of $11.88B.Over the past 30 days, its market cap has decreased by -5.97%, while in the last 12 months, it has …

public.com

FAQs about TECH News Today | Why did Bio-Techne stock go up today? Coupon?

Is Bio-Techne Corporation's stock performing well?

Bio-Techne Corporation's (NASDAQ:TECH) stock is performing well, having increased by 5.4% over the past month. Given that stock prices are usually influenced by a company's financial performance, it's worth considering Bio-Techne's recent financials. ...

Is Bio-Techne (bio) a great stock to buy?

Bio-Techne has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. ...

Should you buy Bio-Techne (tech) stock in 2024?

In 2024, Bio-Techne's revenue was $1.16 billion, an increase of 1.97% compared to the previous year's $1.14 billion. Earnings were $168.07 million, a decrease of -41.07%. According to 8 analysts, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $82.0, which is an increase of 14.72% from the latest price. ...

Will Bio-Techne Corporation (tech) stock cap a solid 2024?

The stock market rallied in November and December of 2016 and 2020 post-election, and investors are hoping for more of the same to cap a solid 2024 for stocks. Find the latest Bio-Techne Corporation (TECH) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

Will Bio-Techne stock boost market sentiment?

Accordingly, we expect the latest development to boost the market sentiment toward TECH stock. Bio-Techne has a market capitalization of $11.65 billion. The Zacks Consensus Estimate for the company’s fiscal 2025 earnings indicates a 5.1% year-over-year increase on a 5.5% revenue improvement. ...

What is the 12-month price forecast for Bio-Techne Corporation (Tech)?

The 12-month stock price forecast is $82.0, which is an increase of 14.72% from the latest price. MINNEAPOLIS , Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan... ...